D-Allulose: A Review of In Vivo Metabolism, Catalytic Mechanisms, Engineered Strain Construction, and Biosynthesis

A sweetener that fits new product briefs

If you formulate low-calorie foods, D-allulose deserves a closer look. It delivers roughly 70% of sucrose’s sweetness. It brings only 0.2 kcal per gram. That is a 95% calorie cut compared with sugar. The FDA has confirmed it as GRAS. The science behind it just got easier to follow.

What this review covers

The paper appears in Frontiers in Bioengineering and Biotechnology under DOI 10.3389/fbioe.2020.00026. The authors pulled together what we know about D-allulose from several angles. They traced how the body metabolizes it. They examined the catalytic mechanisms enzymes use to make it. They also assessed how engineered microbial strains can improve production.

This last part matters for buyers. The review spends real time on green circular production processes. That means the focus goes beyond a simple enzyme reaction. It points toward manufacturing systems designed to reuse materials and cut waste.

What the evidence shows

The review is not one new experiment. It is a systematic analysis of existing evidence. That makes it a useful reference when you need to explain allulose to a new supplier, a client, or an internal team.

Metric	D-allulose versus sucrose
Sweetness	About 70% of sucrose
Calories	0.2 kcal per gram
Calorie reduction	95% less than sucrose
Regulatory status	FDA GRAS
Food applications	Beverages, baked goods, ice cream, yogurt
Physiological functions	Reduced insulin resistance, blood sugar control, reduced abdominal fat accumulation
Production topics	Enzymatic properties, engineered strain construction, green circular processes

What formulators should take from this

Allulose is not just another bulk sweetener. The review lists beverages, baked goods, ice cream, and yogurt as application targets. That range matters. These categories differ in pH, temperature, and water activity. A sweetener that works across those conditions gives you formulation flexibility.

The metabolic findings are just as interesting. The paper connects D-allulose to insulin resistance and blood sugar control. It also points to reduced abdominal fat accumulation. That opens the door for positioning products around metabolic health, not just calorie reduction.

For ingredient buyers, the production science deserves close attention. The review highlights enzyme characteristics and engineered strains. That tells you the supply side is moving toward biological conversion. Ask suppliers how they make allulose. Do they run a circular process? Can they document enzyme behavior? Those answers reveal a lot about long-term cost and reliability.

Questions formulators ask

Does GRAS status cover every use? The paper confirms FDA GRAS recognition for D-allulose. It does not mean every food category is automatically approved in every country. Check current rules for your target market.

Can I replace all the sugar in a formula? Not without testing. The review gives you the sweetness baseline and metabolic profile. It does not hand you a universal replacement ratio. Browning, texture, and moisture all shift when you swap sugars.

What should I ask a supplier first? Ask about the production route. The review emphasizes enzymatic properties and engineered strains. Ask how the supplier converts sugar into allulose and how they handle process waste. That is where the economics live.

This review will not hand you a finished formula. It gives you something better: a shared reference for R&D, sourcing, and regulatory conversations. The paper maps the science from metabolism to manufacturing. You bring the application. The sugar aisle is changing. Allulose is one reason why.